MENLO PARK, Calif.--(BUSINESS WIRE)-- <\/p>\n
Personalis, Inc. today announced that it will be exhibiting at the European Society of Human Genetics Conference in Paris, France beginning Sunday, June 9, 2013. Personalis will launch its Genome Services for Research and Clinical samples, focusing on accuracy in sequencing, analysis, and interpretation of human genomes to the European market. <\/p>\n
Personalis Genome Services include our Accuracy and Content Enhanced (ACE) Exome technology. Using additional custom targeted capture, we aim to finish genes in the medical exome and add medically interpretable content outside the exons. This has been shown to benefit work in medical genetics, pediatrics, cardiology, neurology, psychiatry, pharmacogenomics, and other areas of medicine. <\/p>\n
Clinical quality genome interpretation also requires accurate and comprehensive databases of genetic variation. Personalis has the largest and most comprehensive manually-curated database in the world linking genetic variation with disease. We have also signed an exclusive license for commercialization of PharmGKB, the premier database linking genetic variation with drug metabolism and adverse events. Personalis also annotates genomes with information from over 30 databases. When combined with Personalis ACE (Accuracy and Content Enhanced) Technology for exome sequencing and powerful variant calling algorithms, researchers and clinicians are able to rapidly obtain the most comprehensive sequence analysis available. Personalis CEO, John West, stated We are pleased to extend this offering to the European community and are committed to expanding our global footprint to enable researchers and clinicians worldwide to take advantage of our products. <\/p>\n
About Personalis <\/p>\n
Personalis provides researchers and clinicians accurate DNA sequencing and interpretation of human genomes. Our ACE (Accuracy and Content Enhanced) Technology can supplement a standard exome or genome, substantially increasing its medically-relevant coverage and accuracy. Personalis builds on that with innovativealgorithms and proprietary databases for alignment, variant calling, annotation, and analysis. With this combination, we provide genomic data and interpretation of the highest accuracy. <\/p>\n
Personalis has an exceptional team of scientific, medical and industry experts. Our R&D team brings directly relevant commercial experience from seven different DNA sequencing companies and scientific & medical expertise from the top universities in the world. This group has been deeply involved in many of the advances of recent years, and has a long track record of peer reviewed publications. We see enormous potential in human genome sequencings next big step: accurate interpretation. <\/p>\n<\/p>\n
<\/p>\n
Link:<\/p>\n
Personalis Announces Participation in the European Society of Human Genetics Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. Continue reading